Optimizing antimicrobial use: challenges, advances and opportunities

Timothy M. Rawson, Richard C. Wilson, Danny O’Hare, Pau Herrero, Andrew Kambugu, Mohammed Lamorde, Matthew Ellington, Pantelis Georgiou, Anthony Cass, William W. Hope, Alison H. Holmes

Research output: Contribution to journalReview articlepeer-review

Abstract

An optimal antimicrobial dose provides enough drug to achieve a clinical response while minimizing toxicity and development of drug resistance. There can be considerable variability in pharmacokinetics, for example, owing to comorbidities or other medications, which affects antimicrobial pharmacodynamics and, thus, treatment success. Although current approaches to antimicrobial dose optimization address fixed variability, better methods to monitor and rapidly adjust antimicrobial dosing are required to understand and react to residual variability that occurs within and between individuals. We review current challenges to the wider implementation of antimicrobial dose optimization and highlight novel solutions, including biosensor-based, real-time therapeutic drug monitoring and computer-controlled, closed-loop control systems. Precision antimicrobial dosing promises to improve patient outcome and is important for antimicrobial stewardship and the prevention of antimicrobial resistance.

Original languageEnglish
JournalNature Reviews Microbiology
DOIs
Publication statusAccepted/In press - 2021

Fingerprint

Dive into the research topics of 'Optimizing antimicrobial use: challenges, advances and opportunities'. Together they form a unique fingerprint.

Cite this